SynthesisFrontiers in microbiology2026
STROBE-causal machine learning for the human microbiome: systematic review on methodological innovations and validation frameworks.
Synthesis in Frontiers in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Host-microbiome interactions in breast cancer progression and treatment response.Frontiers in medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The reproducibility crisis in causal microbiome research necessitates robust validation frameworks. Current studies often face inconsistent validation methods, limited interpretability, and a lack of standardized reporting, creating a gap in reliable causal inference. This systematic review evaluates over 60 peer-reviewed studies published between 2015 and 2024 to: (1) establish benchmarking standards leveraging synthetic data and biological plausibility assessments; (2) compare advanced causal machine learning (ML) methodologies, including Double/Debiased ML, Deep Instrumental Variables (Deep IV), and Directed Acyclic Graphs (DAGs), in their application to microbiome-host systems; and (3) propose the STROBE-CML (Strengthening the Reporting of Observational Studies in Epidemiology-Causal Machine Learning) guidelines to standardize reporting practices. We emphasize critical innovations such as federated validation pipelines and time-series causal discovery frameworks that address these gaps by facilitating scalable, privacy-preserving, and reproducible inference across heterogeneous cohorts. A decision support tool is introduced to guide researchers in selecting appropriate causal ML approaches based on data structure, research question, and computational constraints. By synthesizing methodological advances with rigorous validation paradigms, this review provides a roadmap for generating reliable, biologically interpretable, and clinically translatable causal claims in microbiome science.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.